Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

CAPE-COVID, 2020
 
NCT02517489
RCTHydrocortisoneplaceboCOVID-19 severe or criticallylow
76/73 inconclusive
  • inconclusive 29 % decrease in death or ventilation (PE) with a high degree of certainty due to low risk of bias
COALITION II (Furtado), 2020
 
NCT04321278
RCTHydrocortisonehydroxychloroquineCOVID-19 severe or criticallysome concern
214/183 inconclusive
    REMAP-CAP, fixed 7-day course, 2020
     
    NCT02735707
    RCTHydrocortisonestandard of careCOVID-19 severe or criticallysome concern
    143/108 inconclusive

      PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
      Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).